Quarterly report pursuant to Section 13 or 15(d)

Schedule of Disaggregation by Revenue (Details)

v3.22.2.2
Schedule of Disaggregation by Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Product Information [Line Items]        
Total revenue, net $ 24,200 $ 9,472 $ 100,824 $ 33,885
Diagnostic Services [Member]        
Product Information [Line Items]        
Total revenue, net 20,542 7,142 91,613 27,416
Contract Manufacturing [Member]        
Product Information [Line Items]        
Total revenue, net 2,749 1,120 5,662 4,069
Retail and Others [Member]        
Product Information [Line Items]        
Total revenue, net 357 1,210 1,369 2,400
Genomic Products and Services [Member]        
Product Information [Line Items]        
Total revenue, net $ 552 $ 2,180